Search This Blog

Thursday, September 26, 2013

Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly's Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes (NYSE:LLY)

Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly's Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.